NRT GUM
Place in Therapy
Place in therapy
Nicotine gum helps individuals who wish to quit smoking by decreasing the withdrawal symptoms that are common with smoking cessation. The gum provides nicotine to the individual to help ease the craving of a cigarette. Nicotine gum has been available without a prescription for several years and comes as 2mg or 4 mg strengths and sold under the name Nicorette or Thrive.
Nicotine gum can be used as monotherapy or with a nicotine patch. The choice to use nicotine gum comes from the patient’s preference as several other formulations are available including patch, lozenge, and inhaler. The gum provides an individual an immediate release of nicotine while a patch would provide a steady release of nicotine into the user’s body to help cravings.
References
1. Doering P.L., Li R.M. (2011). Chapter 75. Substance-Related Disorders: Alcohol, Nicotine, and Caffeine. In R.L. Talbert, J.T. DiPiro, G.R. Matzke, L.M. Posey, B.G. Wells, G.C. Yee (Eds), Pharmacotherapy: A Pathophysiologic Approach, 8e. Retrieved July 1, 2012 from http://www.accesspharmacy.com.proxy.lib.uwaterloo.ca/content.aspx?aID=7987625
2. Patient Self-Care: Helping your patients make therapeutic choices. Second edition. Ottawa, ON: Canadian Pharmacists Association; 2010: 48-64.
Nicotine gum helps individuals who wish to quit smoking by decreasing the withdrawal symptoms that are common with smoking cessation. The gum provides nicotine to the individual to help ease the craving of a cigarette. Nicotine gum has been available without a prescription for several years and comes as 2mg or 4 mg strengths and sold under the name Nicorette or Thrive.
Nicotine gum can be used as monotherapy or with a nicotine patch. The choice to use nicotine gum comes from the patient’s preference as several other formulations are available including patch, lozenge, and inhaler. The gum provides an individual an immediate release of nicotine while a patch would provide a steady release of nicotine into the user’s body to help cravings.
References
1. Doering P.L., Li R.M. (2011). Chapter 75. Substance-Related Disorders: Alcohol, Nicotine, and Caffeine. In R.L. Talbert, J.T. DiPiro, G.R. Matzke, L.M. Posey, B.G. Wells, G.C. Yee (Eds), Pharmacotherapy: A Pathophysiologic Approach, 8e. Retrieved July 1, 2012 from http://www.accesspharmacy.com.proxy.lib.uwaterloo.ca/content.aspx?aID=7987625
2. Patient Self-Care: Helping your patients make therapeutic choices. Second edition. Ottawa, ON: Canadian Pharmacists Association; 2010: 48-64.